- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1289
0 new
Companies which are more than 50% undervalued based on analyst price target.
1,289 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PAPL | US$0.41 | -8.4% | -72.4% | US$3.6m | US$5.00 | PS1.2x | E31.6% | n/a | Diversified Financials | ||
BTTR | US$1.84 | -10.7% | -76.4% | US$3.4m | US$10.00 | PS0.1x | E180.8% | n/a | Food, Beverage & Tobacco | ||
GNPX | US$0.39 | -10.8% | -91.0% | US$3.3m | US$7.50 | PB2x | E-16.3% | n/a | Pharmaceuticals & Biotech | ||
SXTP | US$0.45 | -23.9% | -87.0% | US$3.3m | US$3.40 | PS7.2x | E-1.1% | n/a | Pharmaceuticals & Biotech | ||
PRSO | US$0.94 | 5.1% | -38.9% | US$3.3m | US$3.35 | PS0.3x | E56.0% | n/a | Semiconductors | ||
SBIG | US$0.07 | 0% | -53.3% | US$3.2m | US$1.00 | PS0.1x | E156.9% | n/a | Software | ||
SNES | US$3.03 | -11.2% | -65.9% | US$3.1m | US$10.00 | PS1.9x | E17.3% | n/a | Pharmaceuticals & Biotech | ||
ICON | US$0.29 | -17.2% | n/a | US$3.1m | US$1.25 | PE7x | S49.0% | 117.7% | Transportation | ||
XPON | US$1.44 | -0.7% | -99.6% | US$3.0m | US$4.00 | PS0.7x | E75.7% | n/a | Capital Goods | ||
YCBD | US$0.45 | -7.0% | -36.4% | US$2.8m | US$2.00 | PS0.1x | E95.3% | n/a | Pharmaceuticals & Biotech | ||
XYLO | US$3.81 | -21.4% | -50.4% | US$2.8m | US$12.00 | PS0.05x | S34.4% | n/a | Healthcare | ||
VTAK | US$0.35 | -10.3% | -91.5% | US$2.8m | US$2.00 | PS7x | E20.4% | n/a | Healthcare | ||
VINC | US$1.24 | -4.6% | -98.3% | US$2.8m | US$120.00 | PB0.3x | E-0.3% | n/a | Pharmaceuticals & Biotech | ||
NAYA | US$0.38 | 8.7% | n/a | US$2.7m | US$2.00 | PE-0.2x | E-33.1% | n/a | Healthcare | ||
OMQS | US$0.25 | 5.4% | -41.0% | US$2.7m | US$3.00 | PS0.04x | E118.5% | n/a | Software | ||
PALI | US$0.94 | -9.3% | -84.4% | US$2.6m | US$30.33 | PB0.4x | E-30.3% | n/a | Pharmaceuticals & Biotech | ||
ATXI | US$1.36 | 0% | -86.5% | US$2.6m | US$8.00 | PB1x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
DRMA | US$1.25 | 5.0% | -82.3% | US$2.6m | US$6.00 | PB0.5x | E-14.0% | n/a | Pharmaceuticals & Biotech | ||
PCSA | US$0.53 | -11.8% | -75.9% | US$2.5m | US$6.00 | PB0.7x | E-5.7% | n/a | Pharmaceuticals & Biotech | ||
BBLG | US$1.01 | -2.9% | -71.9% | US$2.5m | US$16.75 | PB0.7x | E30.7% | n/a | Pharmaceuticals & Biotech | ||
MYSZ | US$1.93 | 7.8% | -48.6% | US$2.4m | US$3.00 | PS0.3x | S8.5% | n/a | Software | ||
NDRA | US$4.33 | -13.5% | -99.8% | US$2.3m | US$2,625.00 | PB0.4x | E-16.8% | n/a | Healthcare | ||
SNAX | US$0.56 | -25.0% | -58.1% | US$2.3m | US$4.00 | PS0.1x | n/a | n/a | Food, Beverage & Tobacco | ||
AUUD | US$0.38 | -21.7% | -90.1% | US$2.2m | US$25.00 | PB0.4x | E5.9% | n/a | Software |